| Primary |
| Chronic Myeloid Leukaemia |
64.7% |
| Leukaemia |
9.2% |
| Hypertension |
6.4% |
| Chronic Myeloid Leukemia |
3.7% |
| Blood Cholesterol Increased |
1.4% |
| Chronic Myeloid Leukaemia (In Remission) |
1.4% |
| Chronic Myeloid Leukemia Without Mention Of Remission |
1.4% |
| Neoplasm Malignant |
1.4% |
| Anxiety |
0.9% |
| Chromosome Analysis Abnormal |
0.9% |
| Chronic Leukaemia |
0.9% |
| Chronic Myelogenous Leukemia |
0.9% |
| Diabetes Mellitus |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Hypothyroidism |
0.9% |
| Leukemia |
0.9% |
| Nausea |
0.9% |
| Pain |
0.9% |
| Vomiting |
0.9% |
| Acute Promyelocytic Leukaemia |
0.5% |
|
| Diarrhoea |
24.4% |
| Vomiting |
14.4% |
| Nausea |
13.9% |
| Rash |
10.6% |
| Death |
5.6% |
| Fatigue |
3.3% |
| Disease Progression |
2.8% |
| Drug Intolerance |
2.2% |
| Headache |
2.2% |
| Pancreatitis |
2.2% |
| Platelet Count Decreased |
2.2% |
| Pleural Effusion |
2.2% |
| Weight Decreased |
2.2% |
| Malaise |
1.7% |
| Pain |
1.7% |
| Pyrexia |
1.7% |
| Rash Pruritic |
1.7% |
| Somnolence |
1.7% |
| Thrombocytopenia |
1.7% |
| Weight Increased |
1.7% |
|
| Secondary |
| Chronic Myeloid Leukaemia |
55.4% |
| Diarrhoea |
7.7% |
| Hypertension |
4.6% |
| Leukaemia |
4.6% |
| Anxiety |
3.1% |
| Constipation |
3.1% |
| Back Pain |
1.5% |
| Blast Crisis In Myelogenous Leukaemia |
1.5% |
| Bronchial Neoplasm |
1.5% |
| Chromosome Analysis Abnormal |
1.5% |
| Chronic Myelogenous Leukemia |
1.5% |
| Chronic Myeloid Leukaemia (In Remission) |
1.5% |
| Deep Vein Thrombosis |
1.5% |
| Depression |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Gout |
1.5% |
| Hypothyroidism |
1.5% |
| Iron Deficiency Anaemia |
1.5% |
| Leukaemia Recurrent |
1.5% |
| Lung Neoplasm Malignant |
1.5% |
|
| Oesophageal Disorder |
14.3% |
| Vomiting |
14.3% |
| Diarrhoea |
8.6% |
| Weight Increased |
8.6% |
| Disease Progression |
5.7% |
| Nausea |
5.7% |
| Weight Decreased |
5.7% |
| Chest Discomfort |
2.9% |
| Drug Intolerance |
2.9% |
| Dysphagia |
2.9% |
| Fall |
2.9% |
| Gastrointestinal Tract Irritation |
2.9% |
| Hepatic Enzyme Increased |
2.9% |
| Hepatotoxicity |
2.9% |
| Ill-defined Disorder |
2.9% |
| Pain |
2.9% |
| Pleural Effusion |
2.9% |
| Proctalgia |
2.9% |
| Pyrexia |
2.9% |
| Rash |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
55.6% |
| Chronic Myeloid Leukaemia |
22.2% |
| Anaemia |
11.1% |
| Endometriosis |
11.1% |
|
| Gastroenteritis Viral |
25.0% |
| Rash Erythematous |
25.0% |
| Skin Discolouration |
25.0% |
| Weight Decreased |
25.0% |
|
